For instance, inhibiting PTPN21 to curb the proliferation of ALL cells, in conjunction with TKIs or other immunotherapies, could further bolster the eradication capabilities against tumor cells. The gene discussed is PTPN21; the disease is acute lymphoblastic leukemia.